Court Awards Integra LifeSciences $6.4M In Patent Suit Vs. Merck KGaA

Law360, New York (September 28, 2004, 12:00 AM EDT) -- In a widely watched case that hinged on the exemption from patent infringement claims enjoyed by drug makers during their research and development, a federal court has reduced medical device maker Integra LifeSciences’ damages award in its lawsuit against Merck KGaA from $15 million to $6.4 million.

The ruling by the U.S. District Court for the Southern District of California follows a June 2003 order of the U.S. Court of Appeals for the Federal Circuit affirming the trial court's earlier finding that Merck KGaA had infringed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.